Keyphrases
Serine Racemase
100%
Overactivation
100%
Serine Racemase Inhibitors
100%
NMDA-type Glutamate Receptor
75%
Therapeutic Strategies
25%
Neurodegenerative Diseases
25%
Neurotoxicity
25%
IC50 Value
25%
Inhibitory Activity
25%
Physiological Function
25%
Disease States
25%
Protective Effect
25%
Recombinant
25%
Neurodegeneration
25%
In Silico Screening
25%
Epilepsy
25%
Gene Knockout Mice
25%
Co-agonist
25%
In Vitro Evaluation
25%
Hit Compound
25%
Neuroscience
In Vivo
100%
Serine Racemase
100%
N-Methyl-D-Aspartic Acid
80%
Glutamate Receptor
60%
Serine
60%
In Vitro
40%
Neurodegenerative Disorder
20%
Neurodegeneration
20%
Gene Knockout
20%
Excitotoxicity
20%
Medicine and Dentistry
Serine
100%
Racemase
100%
N-Methyl-D-Aspartic Acid
50%
Glutamate Receptor
37%
In Vitro
25%
IC50
12%
Disease
12%
Gene Targeting
12%
In Silico
12%
Neurodegenerative Disorder
12%
Neurodegeneration
12%
Gene Knockout
12%
Excitotoxicity
12%
Pharmacology, Toxicology and Pharmaceutical Science
Serine
100%
Racemase
100%
N Methyl Dextro Aspartic Acid
50%
Glutamate Receptor
37%
Disease
25%
Knockout Mouse
12%
IC50
12%
Nerve Degeneration
12%
Excitotoxicity
12%